Lightyear Capital completed the investment in CuraLinc Healthcare.

Lightyear Capital, a New York-based private equity firm focused on financial services, completed the investment in CuraLinc Healthcare, provider of employee assistance, student and workforce mental health programs, including personalized solutions that engage, empower, and support employees, members, and students throughout their mental health care journey. Financial terms were not disclosed. “We are excited to partner with the entire CuraLinc team. The CuraLinc investment continues Lightyear’s long history and experience in healthcare, employee benefits and insurance distribution, including our successful exits of Therapy Brands, Alegeus and Datalot. We look forward to supporting CuraLinc’s leadership in this next phase of growth,” Mark Vassallo, Lightyear Managing Partner.